W-0180

N/A

Report date: 2024/06/28 11:33:43

Base Information

Drug NameW-0180

Drug Alias NameW-0180

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionV-domain Ig suppressor of T-cell activation inhibitorsT lymphocytes stimulantsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects

TargetsV-domain Ig suppressor of T-cell activation

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFranceSpain

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPierre Fabre Medicament

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPierre Fabre Medicament

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A